Department of Plastic Surgery, Kuopio University Hospital, Kuopio, Finland.
J Reconstr Microsurg. 2009 Nov;25(9):521-6. doi: 10.1055/s-0029-1238218. Epub 2009 Sep 22.
Few studies have examined the cost-effectiveness of microsurgery, and little is known about the cost-effectiveness of flap monitoring. We studied the costs related to microsurgery during 2004 to 2006 in Kuopio University Hospital. A total of 99 patients were reconstructed with 109 flaps. Primary success was achieved in 64% of cases. Reoperation for anastomosis was conducted in 25% and for other surgical complications in 27%. The intended result was achieved in 94% of cases. The mean total cost of hospital care was 20,000 euro in head and neck cancer surgery, 15,500 euro in defects of the lower extremities, and 9200 euro in breast reconstruction. The costs were greatly influenced by surgical complications (i.e., if the primary reconstruction failed, then the secondary microvascular flap almost doubled the expense involved; mean expenses per case 27,900 euro). Microdialysis was used in flap monitoring with an additional cost of 535 euro per patient. We found that microdialysis provided an early diagnosis of perfusion failure and helped to save the flap. It was estimated that if one or two flaps per year are saved due to more effective monitoring, then the extra costs of using microdialysis are covered.
鲜有研究考察过显微外科的成本效益,对于皮瓣监测的成本效益更是知之甚少。我们研究了 2004 年至 2006 年期间在库奥皮奥大学医院进行的显微外科相关成本。共有 99 名患者接受了 109 个皮瓣重建。初次手术成功率为 64%。吻合口再手术的比例为 25%,其他手术并发症为 27%。94%的病例达到了预期的效果。头颈部癌症手术的平均总住院费用为 20000 欧元,下肢缺损为 15500 欧元,乳房重建为 9200 欧元。手术并发症极大地影响了成本(即,如果初次重建失败,那么二次微血管皮瓣几乎使费用增加了一倍;每个病例的平均费用为 27900 欧元)。皮瓣监测中使用微透析的额外费用为每位患者 535 欧元。我们发现,微透析可以早期诊断灌注失败,并有助于挽救皮瓣。据估计,如果每年能因更有效的监测而挽救一个或两个皮瓣,那么使用微透析的额外成本就可以得到弥补。